Coronavirus: Combination of two anti-HIV drugs proved crucial in treatment, Rajasthan official

Image
Press Trust of India Jaipur
Last Updated : Mar 16 2020 | 4:38 PM IST

A combination of two anti-HIV drugs has proved crucial in the treatment of coronavirus positive cases, a senior official of the Rajasthan government said.

Additional Chief Secretary (Medical and Health) Rohit Kumar Singh said the patients' condition improved after they were administered the anti-HIV drugs.

Three of the four patients in the state have now been declared coronavirus-free.

Singh said the first two patients tested positive for the virus were an Italian couple.

"Their symptoms were flu-like so they were initially given anti-malaria and anti-swine flu drugs," he said.

"All this while, our doctors were in touch with the Indian Council of Medical Research and the Drug Controller General of India. Since the structure of coronavirus is similar to that of HIV to some extent, so they tried a combination of the two anti-HIV drugs," he added.

"It appears it (combination of drugs) is working because three patients have recovered. Good thing is that all the three patients are elderly and the successful result of the drug on patients of such age is a big thing," he said.

Dr D S Meena, Superintendent of the SMS Hospital, where all the three patients were treated, said the combination of the anti-HIV drugs proved useful in treating the patients.

He informed that after recovering from the virus, the Italian woman has already been shifted from the SMS Hospital to a quarantine facility at the Rajasthan University of Health Sciences.

Her husband and a Jaipur based 85-year-old man are being shifted from isolation ward to the ICU within the SMS Hospital after they recovered from coronavirus.

The fourth positive case, a 24-year-old man, is being treated at the isolation facility of the Jaipur hospital.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 16 2020 | 4:38 PM IST

Next Story